CLINICAL_TRIALS
trial_result
· 2022-02-07
Clinical Trial Update: To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol [Phase 2]
Summary
Phase 2 trial assessing the protective effect of a fixed combination of disodium cromoglycate and reproterol in asthma with exercise-induced symptoms; study com…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: MEDA Pharma GmbH & Co. KG | Conditions: Asthma, Exercise-Induced | Phase 2 | Status: COMPLETED